Study to Evaluate LPH-5 in Healthy Subjects

Launched by LOPHORA · Dec 3, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to study a new treatment called LPH-5 to see if it is safe for healthy volunteers. Researchers want to understand how the body processes this treatment and how it affects the body. The trial is currently not recruiting participants, but when it starts, it will involve male volunteers aged between 65 and 74 years.

To be eligible for this study, participants must be in good health, as determined by a doctor’s evaluation, which includes checking their medical history and conducting various health tests. However, individuals with certain health conditions or who use cannabis frequently may not be able to participate. If you join the study, you can expect to undergo a series of health checks and evaluations to ensure your safety throughout the trial. This study aims to gather important information that could help in the development of LPH-5 for future use.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Healthy as determined by a responsible physician, based on medical evaluation including medical history, physical examination, concomitant medication, vital signs, 12-lead ECG, and clinical laboratory evaluations.
• Exclusion Criteria:
• • Any condition or disease detected during the medical interview/physical examination that could relapse during or immediately after the study, or would render the participant unsuitable for the study, place the participant at undue risk, or interfere with the ability of the participant to complete the clinical study, as determined by the Investigator.
• • Have a history of and/or current clinically significant determined by the Investigator
• • Consumes cannabis or cannabis-derived compounds more than 3 times per month or has substantial changes in cannabis consumption in the 21 days prior to screening.